162 related articles for article (PubMed ID: 34674139)
1. Role of NRF2 cascade in determining the differential response of cervical cancer cells to anticancer drugs: an in vitro study.
Ramesh PS; Raja S; Udayakumar SH; Chandrashekar S; Nataraj SM; Devegowda D
Mol Biol Rep; 2022 Jan; 49(1):109-119. PubMed ID: 34674139
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
3. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
Su J; Zhang F; Li X; Liu Z
Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
[TBL] [Abstract][Full Text] [Related]
4. Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor- kappa B (NF-κB) pathway.
Aktepe OH; Şahin TK; Güner G; Arik Z; Yalçin Ş
Turk J Med Sci; 2021 Feb; 51(1):368-374. PubMed ID: 32718121
[TBL] [Abstract][Full Text] [Related]
5. Erastin induces ferroptosis in cervical cancer cells via Nrf2/HO-1 signaling pathway.
Wei X; Huang Q; Huang J; Yu L; Chen J
Int J Immunopathol Pharmacol; 2023; 37():3946320231219348. PubMed ID: 38031977
[TBL] [Abstract][Full Text] [Related]
6. 4-methoxychalcone enhances cisplatin-induced oxidative stress and cytotoxicity by inhibiting the Nrf2/ARE-mediated defense mechanism in A549 lung cancer cells.
Lim J; Lee SH; Cho S; Lee IS; Kang BY; Choi HJ
Mol Cells; 2013 Oct; 36(4):340-6. PubMed ID: 24046186
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
8. Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK/NF-κB pathway.
Zhang J; Zhang Y; Liu S; Zhang Q; Wang Y; Tong L; Chen X; Ji Y; Shang Q; Xu B; Chu M; Wei L
Tumour Biol; 2013 Aug; 34(4):2433-40. PubMed ID: 23595222
[TBL] [Abstract][Full Text] [Related]
9. The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours.
Hannon Barroeta P; O'Sullivan MJ; Zisterer DM
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8379-8391. PubMed ID: 37079050
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
11. Cellular levels of oxidative stress affect the response of cervical cancer cells to chemotherapeutic agents.
Filippova M; Filippov V; Williams VM; Zhang K; Kokoza A; Bashkirova S; Duerksen-Hughes P
Biomed Res Int; 2014; 2014():574659. PubMed ID: 25478571
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression.
Wu J; Zhang L; Li H; Wu S; Liu Z
Biochem Biophys Res Commun; 2019 Oct; 518(4):698-705. PubMed ID: 31472965
[TBL] [Abstract][Full Text] [Related]
13. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.
Chian S; Li YY; Wang XJ; Tang XW
Asian Pac J Cancer Prev; 2014; 15(6):2911-6. PubMed ID: 24761924
[TBL] [Abstract][Full Text] [Related]
14. Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway.
Qaisiya M; Coda Zabetta CD; Bellarosa C; Tiribelli C
Cell Signal; 2014 Mar; 26(3):512-20. PubMed ID: 24308969
[TBL] [Abstract][Full Text] [Related]
15. Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.
Kontostathi G; Zoidakis J; Makridakis M; Lygirou V; Mermelekas G; Papadopoulos T; Vougas K; Vlamis-Gardikas A; Drakakis P; Loutradis D; Vlahou A; Anagnou NP; Pappa KI
Biomed Res Int; 2017; 2017():4180703. PubMed ID: 28261610
[TBL] [Abstract][Full Text] [Related]
16. The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress.
Sahoo K; Dozmorov MG; Anant S; Awasthi V
Invest New Drugs; 2012 Apr; 30(2):558-67. PubMed ID: 21181232
[TBL] [Abstract][Full Text] [Related]
17. Curcumin induces ER stress-mediated apoptosis through selective generation of reactive oxygen species in cervical cancer cells.
Kim B; Kim HS; Jung EJ; Lee JY; K Tsang B; Lim JM; Song YS
Mol Carcinog; 2016 May; 55(5):918-28. PubMed ID: 25980682
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells.
Khalil HS; Langdon SP; Goltsov A; Soininen T; Harrison DJ; Bown J; Deeni YY
Oncotarget; 2016 Nov; 7(46):75874-75901. PubMed ID: 27713148
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
Yang F; Guo L; Cao Y; Li S; Li J; Liu M
Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
[TBL] [Abstract][Full Text] [Related]
20. Characterization of adult α- and β-globin elevated by hydrogen peroxide in cervical cancer cells that play a cytoprotective role against oxidative insults.
Li X; Wu Z; Wang Y; Mei Q; Fu X; Han W
PLoS One; 2013; 8(1):e54342. PubMed ID: 23349856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
